BAX
$52.02
Baxter International
$.33
.64%
BAX
Earnings Whisper ®
N/A
1st Quarter March 2017
Consensus:  $0.51
Revenue:  $2.45 Bil
Wednesday
Apr 26
7:15 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, February 01, 2017

What do you expect when BAX reports earnings?
Beat
Meet
Miss

Where is BAX's stock price going from here?
Up
Flat
Down
Stock chart of BAX
Analysts
Summary of analysts' recommendations for BAX
Score
Grade
Pivots
Resistance
$52.89
$52.54
$52.28

$51.93

Support
$51.67
$51.32
$51.06
Tweet
Growth
Description
Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.
Peers
StrykerBoston ScientificAbbott LaboratoriesIntegra LifeSciences HoldingsWatersBecton, DickinsonC. R. Bard3MResMedHaemonetics